Stempoint Capital »

Arcturus Therapeutics Hldg I shares owned by Stempoint Capital

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $656k 36k 18.43

More positions owned by Stempoint Capital

Roivant Sciences SHS (ROIV)
Uniqure Nv SHS (QURE)
Immunovant (IMVT)
Scholar Rock Hldg Corp (SRRK)
Denali Therapeutics (DNLI)
Syndax Pharmaceuticals (SNDX)
Biohaven (BHVN)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Wave Life Sciences SHS (WVE)
Cidara Therapeutics Com New (CDTX)
Abivax Sa Sponsored Ads (ABVX)
Ideaya Biosciences (IDYA)
Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Surrozen Com New (SRZN)

View all positions for Stempoint Capital

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
BlackRock
Balyasny Asset Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Vanguard Group
ARK Investment Management
State Street Corporation
Susquehanna International
Schonfeld Strategic Advisors
Geode Capital Management
Morgan Stanley
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
Caption Management

View all funds holding Arcturus Therapeutics Hldg I